1. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway
   Bo Li et al, 2016, Oncotarget CrossRef
2. Network Analysis Identifies Phase Transitions for Tumor With Interacting Cells
   Amir Hossein Darooneh et al, 2022, Frontiers in Physiology CrossRef
3. P21 activated kinase 2 promotes pancreatic cancer growth and metastasis
   Guo‑Wang Yao et al, 2019, Oncology Letters CrossRef
4. Systemic biological study for identification of miR-299-5p target genes in cancer
   Saeideh Gholamzadeh Khoei et al, 2020, Meta Gene CrossRef
5. The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease
   Honglin Xu et al, 2022, International Journal of Drug Discovery and Pharmacology CrossRef
6. A Novel and Validated 8-Pyroptosis-Related Genes Based Risk Prediction Model for Diffuse Large B Cell Lymphoma
   Junrui Ma et al, 2022, Biomolecules CrossRef
7. The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
   Angela Cho et al, 2015, Frontiers in Oncology CrossRef
8. Migration dynamics of ovarian epithelial cells on micro-fabricated image-based models of normal and malignant stroma
   Samuel Alkmin et al, 2019, Acta Biomaterialia CrossRef
9. Image Processing and Analysis in Lung Cancer Cells Growth
   Przemysław Jędrusik et al, 2018, Proceedings of the 10th International Conference on Computer Recognition Systems CORES 2017 CrossRef
10. Targeting Rho, Rac, CDC42 GTPase Effector p21 Activated Kinases in Mutant K-Ras-Driven Cancer
    A.S. Azmi et al, 2017, Conquering RAS CrossRef
11. A novel electrochemical immunosensor based on disposable ITO-PET electrodes for sensitive detection of PAK 2 antigen
    Burçak Demirbakan et al, 2019, Journal of Electroanalytical Chemistry CrossRef
12. miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
    Xiaotang Yu et al, 2020, Cancer Cell International CrossRef
13. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
    Sabrina J. Ritch et al, 2022, Cancer Cell International CrossRef
14. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
    Eric N. Horst et al, 2021, Acta Biomaterialia CrossRef
15. Injectable three-dimensional tumor microenvironments to study mechanobiology in ovarian cancer
    Eric N. Horst et al, 2022, Acta Biomaterialia CrossRef
16. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2
    Hao Yang et al, 2024, Frontiers in Immunology CrossRef
17. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis
    Chi Zhang et al, 2018, International Journal of Cancer CrossRef
18. Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
    Xing-Hua Xiao et al, 2018, Molecules CrossRef
19. Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment?
    Adrien Crestani et al, 2020, Gynecologic Oncology CrossRef
20. Automatic segmentation of lung cancer cells with the new parameters by using methods of image processing and analysis
    Przemysław Jędrusik et al, 2018, Innovations in Biomedical Engineering CrossRef
21. Extracellular Matrix: A Treasure Trove in Ovarian Cancer Dissemination and Chemotherapeutic Resistance
    Surbhi Valmiki et al, 2021, Cureus CrossRef
22. Molecular mechanisms of microRNA-216a during tumor progression
    Amir Abbas Hamidi et al, 2023, Cancer Cell International CrossRef
23. Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1
    Leo Edlinger et al, 2017, British Journal of Haematology CrossRef